Gail Boudreaux

President and CEO

Gail Boudreaux (President and CEO) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Elevance Health, Inc. (ELV). Across 1 priced purchase filing, the average 21-session return was +7.2% from execution and +7.2% from disclosure (delay-adjusted; derived). The largest single filing was $1.0M of ELV (2,725 sh across 2 lots, as filed), executed Jul 17.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

+7.2%

avg across 1 priced filings

Delay-adjustediThe same average, entered at disclosure dates

+7.2%

same 1 filings, from disclosure

Filings, ttm

1 buys · 0 sells

Median delay

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.0M

shares × price, as filed

Last traded

Jul 17

Filed Jul 17

Median ADV $656.7M across their filed names

Open performance→

Volume by month

Buys $3.4M Sells $0

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names

ELV

Elevance Health, Inc. ELV · 2 buys · 0 sells 2 filings

Recent filings

ELVPURCHASE Elevance Health, Inc. View filing → $1.0M
2,725 sh across 2 lots
Exec Jul 17
Filed Jul 17 · 1:50 PM ET ELVPURCHASE Elevance Health, Inc. View filing → $2.4M
8,500 sh across 3 lots
Exec Jul 18 2025
Filed Jul 18 2025 · 1:42 PM ET